In a small study, MRI brain scans predicted with 89 percent accuracy who would go on to develop dementia within three years.

The discovery could lead to reducing risk of Alzheimer's disease by targeting the right genes and proteins to manage cholesterol and triglycerides.

The scaffold, which delivers stem cells and is biodegradable, could help treat Alzheimer's and Parkinson's diseases, as well as spine and brain injuries.